Get the Stockscreener App
0.70
10.26%
-0.08
Vicarious Surgical Inc stock is traded at $0.70, with a volume of 35,092.
It is down -10.26% in the last 24 hours and up +66.67% over the past month.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.
See More
Previous Close:
$0.78
Open:
$0.79
24h Volume:
35,092
Relative Volume:
0.34
Market Cap:
$4.98M
Revenue:
-
Net Income/Loss:
$-50.18M
P/E Ratio:
-0.0848
EPS:
-8.2506
Net Cash Flow:
$-45.31M
1W Performance:
-7.89%
1M Performance:
+66.67%
6M Performance:
-89.51%
1Y Performance:
-87.80%
1-Day Range:
$0.65
$0.8703
1-Week Range:
$0.65
$0.8703
52-Week Range:
$0.35
$13.75
Vicarious Surgical Inc Stock (RBOT) Company Profile
Name
Vicarious Surgical Inc
Sector
Industry
Phone
(617) 868-1700
Address
78 FOURTH AVENUE, WALTHAM
Compare RBOT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
0.70 | 13.67M | 0 | -50.18M | -45.31M | -8.2506 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Vicarious Surgical Inc Stock (RBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-07-22 | Initiated | Credit Suisse | Outperform |
| Dec-07-21 | Initiated | Cowen | Outperform |
| Nov-05-21 | Initiated | Canaccord Genuity | Buy |
| Oct-18-21 | Initiated | BTIG Research | Buy |
| Oct-07-21 | Initiated | Piper Sandler | Overweight |
View All
Vicarious Surgical Inc Stock (RBOT) Latest News
Aug Reactions: Will Vicarious Surgical Inc outperform tech stocks2026 Technical Overview & Low Drawdown Momentum Ideas - baoquankhu1.vn
If You Invested $1,000 in Vicarious Surgical Inc (RBOT) - Stock Titan
Trend Report: Does Vicarious Surgical Inc Equity Warrant stock benefit from AI growth2026 Support & Resistance & Community Verified Trade Signals - baoquankhu1.vn
Aug Retail: Will Vicarious Surgical Inc Equity Warrant outperform the market in YEARMarket Rally & Daily Growth Stock Investment Tips - baoquankhu1.vn
Vicarious Surgical Inc. Files Form 8-K Current Report – Company Information, Address, and Key Identifiers (April 2026) 23 - Minichart
Vicarious Surgical Shareholders Approve Reverse Stock Split Authorization - TipRanks
Vicarious Surgical (RBOT) investors back wide-range reverse stock split plan - Stock Titan
Aug Wrap: Is Vicarious Surgical Inc forming a bullish divergencePortfolio Risk Summary & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Innovation Endeavors (RBOT) cuts Vicarious Surgical stake to 3.4% - Stock Titan
Valuation Update: Is Ashford Hospitality Trust Inc impacted by rising ratesOil Prices & Real-Time Market Sentiment Reports - baoquankhu1.vn
Vicarious Surgical Inc. (RBOT) Competitors - Meyka
Vicarious Surgical (RBOT) hit with NYSE delisting, shifts trading to OTCID - Stock Titan
What is Vicarious Surgical Incs valuation compared to sector2026 Breakouts & Daily Price Action Insights - baoquankhu1.vn
Vicarious Surgical completes testing of surgical instrument suite By Investing.com - Investing.com Australia
Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair - The Manila Times
Vicarious Surgical Inc. (RBOT) stock price, news, quote and history - Yahoo Finance UK
Vicarious Surgical Completes Integrated Benchtop Testing of Surgical Instruments - National Today
Vicarious Surgical completes testing of surgical instrument suite - Investing.com
Vicarious Surgical Inc. Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair - marketscreener.com
Vicarious Surgical stock upgrades to OTCQB market By Investing.com - Investing.com Australia
Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing - The Manila Times
Vicarious Surgical stock upgrades to OTCQB market - Investing.com
Vicarious Surgical begins quotation on the OTCQB as part of strategic path toward potential Nasdaq listing - marketscreener.com
Buyback Watch: Will Vicarious Surgical Inc outperform tech stocks2026 Buyback Activity & Daily Entry Point Alerts - baoquankhu1.vn
Reverse split plan at Vicarious Surgical (RBOT) after NYSE delisting - Stock Titan
Vicarious Surgical (RBOT) voluntarily withdraws Class A stock from NYSE listing - Stock Titan
Growth Value: Can Vicarious Surgical Inc beat the S P 5002026 Retail & Daily Profit Maximizing Tips - baoquankhu1.vn
Aug Technicals: Can Vicarious Surgical Inc beat the S P 500Market Performance Recap & Reliable Trade Execution Plans - baoquankhu1.vn
Growth Recap: What is Vicarious Surgical Incs valuation compared to sector2026 Levels & Risk Controlled Swing Alerts - baoquankhu1.vn
Vicarious Surgical sees FY2026 cash burn of $35 million - MSN
Vicarious Surgical applies for Nasdaq listing - MedTech Dive
Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing - Ortho Spine News
Vicarious Surgical announces strategic plan to pursue Nasdaq listing - marketscreener.com
Vicarious Surgical Announces Strategic Plan To Pursue Nasdaq Listing - TradingView
Reverse split proposal aims to relist Class A shares (RBOT) on Nasdaq - Stock Titan
ETFs Investing in Vicarious Surgical, Inc. Class A Stocks - TradingView
Total revenue of Vicarious Surgical Inc. – OTC:RBOT - TradingView
After tax other income/expense of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Non-controlling/minority interest of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Diluted earnings per share (diluted EPS) of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Discontinued operations of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Operating expenses (excl. COGS) of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Preferred dividends of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Dilution adjustment of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Diluted shares outstanding of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Total operating expenses of Vicarious Surgical Inc. – OTC:RBOT - TradingView
Vicarious Surgical Inc. Income Statement – OTC:RBOT - TradingView
The Technical Signals Behind (RBOT) That Institutions Follow - Stock Traders Daily
Vicarious Surgical System: Next-Generation Single-Port Robotic Surgery Platform, FDA Pathway, and Market Strategy Overview - Minichart
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results - Ortho Spine News
Vicarious Surgical Delisted to OTC as Losses Narrow - TipRanks
Vicarious Surgical Inc Stock (RBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):